Effects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study
Open Access
- 28 January 2026
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Abstract
To evaluate the impact of dutasteride, a 5-alpha reductase inhibitor, used alongside intravesical Bacillus Calmette-Guérin therapy on recurrence, progKeywords
This publication has 27 references indexed in Scilit:
- Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database AnalysisClinical Genitourinary Cancer, 2022
- The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, CanadaClinical Genitourinary Cancer, 2021
- Androgen Suppression Therapy Is Associated with Lower Recurrence of Non–muscle-invasive Bladder CancerEuropean Urology Focus, 2021
- The global burden of urinary bladder cancer: an updateWorld Journal of Urology, 2019
- Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent CohortsTranslational Oncology, 2019
- Bladder Cancer Survival of Men Receiving 5α-Reductase InhibitorsJournal of Urology, 2018
- Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase InhibitorJournal of Urology, 2017
- Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEuropean Urology, 2016
- Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen ReceptorThe American Journal of Pathology, 2013
- Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder CancerJournal of Urology, 2012